Legal Representation
Attorney
Andrea P. Nguyen
USPTO Deadlines
Next Deadline
2090 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-22)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 22, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Jul 11, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
Jun 24, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Jun 24, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
Apr 22, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Apr 22, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Mar 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 11, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Feb 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 11, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Feb 11, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 11, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 11, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jan 22, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 22, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 22, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 17, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Jul 29, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Jul 29, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Jul 2, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Jul 1, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 30, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Jan 26, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 25, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; medical research laboratory services; medical research laboratory services; scientific research services for medical purposes; medicine research; scientific analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection and research of medical products; consultancy in the field of testing, inspection, research of medical products; pharmaceutical product evaluation; medical and pharmacological research services; consulting services in the fields of medical research laboratory testing; scientific research in the fields of medicine and health and pharmacology; industrial research in the fields of medicine and health and pharmacology; research in the fields of medicine and surgery and specimen analysis; medical research
Class 044
Medical and health assessment services relating to DNA, genetics and genetic testing; telemedicine services; medical and health care clinic services; medical and health care services; conducting of medical examinations; medical examination services; medical care; medical clinic services; medical information; providing information in the field of medicine; medical screening; provision of information relating to medicine
Additional Information
Design Mark
The mark consists of "BIOSOLVIX" below the Korean characters that transliterate to "BIOSOLVIX".
Other
The non-Latin characters in the mark transliterate to "BIOSOLVIX" and this has no meaning in a foreign language.
Classification
International Classes
042
044